Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BIOSECURE Act
Fierce Pharma
WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
China biopharma contracting juggernaut WuXi AppTec faces new concerns that its extensive business ties to the U.S. could be imperiled.
Kevin Dunleavy
Dec 4, 2025 8:55am
Illumina caught in tariff crossfire as China retaliates
Feb 4, 2025 10:45am
WuXi AppTec sells US device testing business to NAMSA
Jan 17, 2025 10:42am
Biophama VC, deal values and exits all rise in Q3: Pitchbook
Nov 20, 2024 6:15am
WuXi AppTec posts sales decline but picks up new business in Q3
Oct 29, 2024 8:25am
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Aug 23, 2024 4:00am
